Day One Biopharmaceuticals, Inc.
DAWN
$6.78
$0.48467.69%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 473.02M | 531.72M | 558.38M | 361.87M | 317.94M |
| Total Receivables | 18.05M | 13.88M | 8.70M | 9.14M | -- |
| Inventory | 3.57M | 3.32M | 2.74M | 151.00K | -- |
| Prepaid Expenses | 4.28M | 5.20M | 4.80M | 4.39M | 3.51M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 9.73M | 8.22M | 6.38M | 7.61M | 4.58M |
| Total Current Assets | 508.65M | 562.33M | 581.00M | 383.16M | 326.03M |
|
|
|||||
| Total Current Assets | 508.65M | 562.33M | 581.00M | 383.16M | 326.03M |
| Net Property, Plant & Equipment | 5.09M | 4.71M | 3.48M | 360.00K | 444.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 20.41M | 15.63M | 16.22M | 16.80M | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 215.00K | 121.00K | 117.00K | 117.00K | 167.00K |
| Total Assets | 534.36M | 582.79M | 600.81M | 400.44M | 326.65M |
|
|
|||||
| Total Accounts Payable | 2.54M | 3.26M | 3.02M | 6.44M | 4.78M |
| Total Accrued Expenses | 40.58M | 56.46M | 30.69M | 28.94M | 23.89M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 62.00K | 10.00K | 77.00K | 190.00K | 300.00K |
| Total Finance Division Other Current Liabilities | 4.70M | 13.72M | 5.96M | 58.13M | 874.00K |
| Total Other Current Liabilities | 4.70M | 13.72M | 5.96M | 58.13M | 874.00K |
| Total Current Liabilities | 47.88M | 73.45M | 39.75M | 93.71M | 29.84M |
|
|
|||||
| Total Current Liabilities | 47.88M | 73.45M | 39.75M | 93.71M | 29.84M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 2.85M | 2.59M | 2.54M | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 4.11M | 3.99M | 3.06M | -- | -- |
| Total Liabilities | 54.84M | 80.04M | 45.34M | 93.71M | 29.84M |
|
|
|||||
| Common Stock & APIC | 1.07B | 1.06B | 1.04B | 832.16M | 817.81M |
| Retained Earnings | -590.08M | -554.08M | -488.37M | -525.40M | -521.00M |
| Treasury Stock & Other | -52.00K | 84.00K | -6.00K | -22.00K | -5.00K |
| Total Common Equity | 479.51M | 502.75M | 555.46M | 306.73M | 296.81M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 479.51M | 502.75M | 555.46M | 306.73M | 296.81M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 479.51M | 502.75M | 555.46M | 306.73M | 296.81M |
|
|
|||||